Scienture Holdings, Inc. (Nasdaq: SCNX) has entered into a securities purchase agreement with institutional investors to purchase 3,225,000 shares of common stock at $1.20 per share.
The gross proceeds for the offering are expected to be approximately $3.9 million before expenses.
Maxim Group LLC is the sole placement agent for the offering.
Offering Details
3,225,000 shares of common stock at $1.20 per share in a registered direct offering.
Gross Proceeds
Expected to be approximately $3.9 million before deducting fees and expenses.
Closing Date
Expected on August 15, 2025, subject to customary closing conditions.
- The press release highlights Scienture Holdings' focus on providing enhanced value to patients through novel specialty pharmaceutical products.
- The agreement with institutional investors signifies confidence in Scienture's strategic direction and potential growth.
The securities purchase agreement marks a significant step for Scienture Holdings, Inc. in securing funds for its pharmaceutical operations and future development.